November 5, 2014
ASKA Pharmaceutical launched an authorized generic (AG) of Takeda Pharmaceutical’s angiotensin receptor blocker Blopress (candesartan) on September 12. Deliveries of the product totaled over 400 million yen in its first day on the market, but it’s unclear whether it will...read more